Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
413 INR | +1,234.41% | -9.28% | +14.36% |
Sales 2024 | 12.89B 155M | Sales 2025 * | 16.21B 195M | Capitalization | 20.07B 242M |
---|---|---|---|---|---|
Net income 2024 | -5.67B -68.31M | Net income 2025 * | 417M 5.02M | EV / Sales 2024 | 1.04 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.24 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
48.1
x | Employees | 2,361 |
Yield 2024 * |
-
| Yield 2025 * |
0.72% | Free-Float | 40.98% |
Latest transcript on Solara Active Pharma Sciences Limited
1 day | +1,236.67% | ||
1 week | -9.13% | ||
Current month | -1.05% | ||
1 month | -25.27% | ||
3 months | -8.32% | ||
6 months | +23.79% | ||
Current year | +14.55% |
Managers | Title | Age | Since |
---|---|---|---|
Poorvank Purohit
CEO | Chief Executive Officer | - | 03/23/03 |
Sudhir Nambiar
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Operating Officer | 52 | 01/19/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Arun N. Kumar
BRD | Director/Board Member | 63 | - |
Chief Operating Officer | 52 | 01/19/01 | |
Director/Board Member | 40 | 16/19/16 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 112 M€ | +4.61% | - |
Date | Price | Change | Volume |
---|---|---|---|
03/24/03 | 413 | +1,234.41% | 62 708 |
31/24/31 | 418.1 | +0.38% | 108,195 |
30/24/30 | 416.5 | -2.94% | 296,168 |
29/24/29 | 429.1 | -1.98% | 268,058 |
28/24/28 | 437.8 | -3.84% | 119,019 |
Delayed Quote NSE India S.E., June 03, 2024 at 11:41 am IST
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+14.55% | 240M | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
+9.78% | 210B | |
-5.52% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- SOLARA Stock